- High Risk HPV
High Risk HPV is associated with nearly all cases of cervical cancer, and several other types of cancer. HPV is extremely common, but individuals with High Risk HPV types may need additional cancer screening tests.
This test measures high risk Human Papillomavirus genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68
Women over the age of 30 who have high-risk HPV are at an increased risk of developing cervical cancer. For this reason, we recommend this test be taken if you are a woman of the ages 30+ and want to understand your potential risk for cervical cancer.
20% of American women have high-risk HPV, which is passed through sexual contact.
Sexually active women over the age of 18 may take this test. ACOG recommends this type of testing for women over the age of 30.
This test checks for 14 high-risk HPV genotypes in women that cause nearly all cases of cervical cancer, including HPV 16 and 18.
Although this test does not diagnose cervical cancer, this test gives a more complete picture of your cervical cancer risk, so that you and your doctor can make immediate decisions about next steps for prevention.
Virtually all cases of cervical cancer are caused by HPV, and just these two HPV types – 16 and 18 – are responsible for about 70% of all cases. High-risk HPV types cause approximately 5% of all cancers worldwide.
This test will, with greater than 99% accuracy, tell you whether or not you are infected with HPV 16, HPV 18, or twelve other high-risk HPV genotypes: 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68.
The HPV test checks whether or not you test positive for one of the high-risk genotypes of HPV. In the event that your test results are abnormal, an associate from our physician network will contact you directly to discuss your particular case as well as provide information on how to take the next steps to get treatment. We take customer privacy very seriously and will never share your information with a third party with the exception of our partner labs and physician network. Your results will allow you to take immediate steps to better your condition or secure treatment.
There are two classes of HPV - high-risk genotypes and low-risk genotypes.
This test only checks for high-risk genotypes. High-risk genotypes can increase a woman’s risk of forming cervical and other types of genital cancers – like anal or vulvar cancer – if the body is unable to clear the infection on its own. Low-risk HPV virus genotypes, on the other hand, are not correlated with a risk of cervical cancer (but are known to cause genital warts). If you suspect you show signs of genital warts, please see your healthcare provider for treatment.
Although no test can be 100% accurate, the cobas® HPV Test was studied in over 47,000 American women in the landmark ATHENA clinical study. It was the largest US clinical trial to measure the value of high-risk HPV testing, including individual testing for HPV 16 and HPV 18. The study demonstrated that 1 in 10 women who tested positive for HPV 16 or HPV 18 with the cobas® HPV Test had evidence of cervical pre-cancer even though their Pap test result was normal. The results proved that testing for high-risk HPV was more effective than a Pap test alone for the detection of cervical precancerous changes.(1)
This test gives a more complete picture of your cervical cancer risk, so that you and your doctor can make immediate decisions about next steps for prevention.(1) This test does not diagnose cervical cancer. Women should have cervical Pap smears and gynecological exams to look for signs of precancerous changes of the cervix and genital skin that could lead to cancer if not treated. Women with certain changes on their Pap smear who also test positive for high-risk HPV should discuss additional screening and treatment options with their healthcare provider.
There are nearly 200 strains of HPV, and not all forms of HPV are considered dangerous. Most bodies with HPV will be able to resolve the virus on their own with no medical treatment, and most people do not know they are infected because there are very few symptoms associated with HPV. HPV is very common, and anyone who has ever had genital contact with another person (even with protection) can be HPV-positive. Both men and women can get HPV and can pass it to partners without knowing; however, the U.S Food and Drug Administration (FDA) has not approved a test for HPV in men.
- Insurance Coverage FAQ
- When will my results be ready?
- In which states can I purchase a kit?
- How long does the testing process take?
- What biomarkers are included in each panel?
- Should I share my results with my physician?
- Is EverlyWell covered by insurance?
- How do I use HSA/FSA benefits to pay for EverlyWell?
- Will you share these results with my doctor?
- Are your tests available outside of the United States?
- How will I know if I have sexually transmitted HPV?
- Is there a cure for HPV?
- What happens if I find out I have sexually transmitted HPV?
- How common is sexually transmitted HPV?
- Who gets cancer from High Risk HPV infection?
- How often should women get a Pap Smear test?
- How common are HPV associated cancers?
- How can I still get HPV if I received the vaccine?
- Who gets sexually transmitted HPV?
- What is HPV?
- How does High Risk HPV cause cancer?